Latest Blogs

Aug 10, 2017
In a divisive time, I look to my patients and see that there is more that unites us than divides us, and this is worth celebrating.
Aug 04, 2017
Never doubt that your voice and time matter when it comes to trying to change the world in a positive way. We as a community can come together and really make a difference, and you can see it firsthand any weekend in almost any city across the country.
Aug 03, 2017
The line of thinking that women can do without their breasts only makes breast cancer treatment easier for us as physicians, not for our patients. When it's your own body, every organ is vital.
Aug 03, 2017
The program is now available for this year's Research Community Forum Annual Meeting. Dr. Richard L. Schilsky invites you to join this unique event on September 24-25 in Alexandria, VA.
Subscribe to this column

Gilberto Lopes, MD, MBA

Gilberto de Lima Lopes Jr., MD, MBA, FAMS, a medical oncologist, is medical director for international programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor of clinical medicine at the University of Miami in Florida. He returned to the United States after 10 years in Asia and Latin America and has dedicated much of his time to the issues of cancer control and access to medications in low- and middle-income countries. Dr. Lopes is the editor in chief of ASCO's Journal of Global Oncology, associate editor for the ASCO University Editorial Board, 2016-2017 chair of the International Clinical Trials Workshop Working Group, and global health track leader for the Cancer Education Committee, among other volunteer roles. Follow him on Twitter @GlopesMd.

Jul 26, 2017
My coauthors and I identify deficiencies in prevention and screening efforts that could be acted upon to further reduce cervical cancer incidence and mortality in Latin America.
Mar 20, 2017
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Oct 31, 2016
Hope springs eternal in the Brazilian economy and health care system, with cautious optimism for gains in oncology care.
Oct 04, 2016
Inequalities, especially in health care, breed discontent. We need better ways to continue incentivizing the development of new drugs while optimizing access. Biosimilars help, but they won't solve the whole problem.
Aug 01, 2016
The region has seen structural reforms in health care systems, better training of cancer professionals, new initiatives for populations at high risk, expansion of cancer registries and cancer plans, and implementation of policies to improve prevention, early diagnosis, and treatment.
Jul 11, 2016
Follow-on biologics are here to stay, and represent enormous potential for patients with cancer being treated in low- and middle-income countries.

Pages